CSIMarket
 
Rebus Holdings Inc   (NSPX)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 161
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Rebus Holdings Inc
Rebus Holdings Inc is a holding company that operates in various industries and invests in businesses through acquisitions and partnerships. The company aims to create value through its diverse portfolio of investments and strategic collaborations. It may have interests in sectors such as technology, finance, healthcare, renewable energy, and real estate. Rebus Holdings Inc focuses on identifying growth opportunities and supporting the development of its subsidiary companies to maximize returns for its shareholders.


   Company Address: 2629 Townsgate Road Westlake Village 91361 CA
   Company Phone Number: 597-7552   Stock Exchange / Ticker: NSPX
   NSPX is expected to report next financial results on March 30, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Rebus Holdings Inc

Rebus Holdings Inc. Defies Odds: From $-1.365 Mil Net Deficit to $0 Mil Revenue in Q2 2023

Rebus Holdings Inc, a major pharmaceutical preparations company, has recently reported its financial performance for the second quarter of 2023. During this period, the company reached a net income of $0, or $0.00 per share, marking an improvement compared to the previous year's second quarter results of a net loss of $-0.04 per share. It is worth noting that in the preceding reporting season, Rebus Holdings Inc reported a loss of $-0.01 per share.
The significant improvement in bottom-line results is evident as the company generated revenues of $0.043 million, whereas in the same reporting season of the previous year, it suffered a net deficit of $-1.365 million. This positive change can be attributed to Rebus Holdings Inc's strategic focus on enhancing sales.

Rebus Holdings Inc

Rebus Holdings Inc Emerges with Improved Net Shortfall Amidst Challenging Market Conditions

In the latest financial report, Rebus Holdings Inc, a major pharmaceutical preparations company, announced a shortfall of $-0.01 per share for the fiscal period ending March 31, 2023, compared to earnings of $0.00 per share in the previous reporting period.
Despite the setback, the company reported a net shortfall of $-0.424 million in the latest reporting period, an improvement from the deficit of $-0.606 million in the same period a year ago.






 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com